Literature DB >> 7400341

Fibrin cross-linking in congenital factor XIII deficiency.

F Rodeghiero, T Barbui.   

Abstract

Homozygous patients with factor XIII deficiency are devoid of immunologically identifiable A protein, the active enzymatic component. Quantitative studies of transamidase activity of the factor are available in only a few cases, and the fibrin cross-linking pattern is not well known. The present paper deals with the quantitative estimation of factor XIII transamidase activity (dansylcadaverine system), factor XIII molecular subunits, and the corresponding fibrin cross-linking pattern in seven homozygous patients with factor XIII deficiency. The results indicate that transamidase activity was present in all patients, and the range was 0.5-1.7%. The pattern of fibrin stabiisation showed an absence of cross-linking in two patients, the presence of gamma-gamma-dimers (traces) in four, and gamma-gamma-dimers plus incomplete alpha-polymers (traces) in one patient. In conclusion, the homozygous patients reported here were not completely devoid of functioning factor XIII.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400341      PMCID: PMC1146106          DOI: 10.1136/jcp.33.5.434

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

2.  Documentation of the plasma factor XIII deficiency in man.

Authors:  F Duckert
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

3.  [Molecular structure of human fibrin stabilizing factors].

Authors:  H Bohn; H Haupt; T Kranz
Journal:  Blut       Date:  1972-10

4.  The half-life of factor XIII in vivo.

Authors:  K Miloszewski; M S Losowsky
Journal:  Br J Haematol       Date:  1970-12       Impact factor: 6.998

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Gel electrophoresis for assessing fibrin crosslinking: a precaution.

Authors:  J S Finlayson; R O Morton
Journal:  Clin Chim Acta       Date:  1972-01       Impact factor: 3.786

7.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

8.  [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine].

Authors:  J J Pisano; J S Finlayson; M P Peyton
Journal:  Science       Date:  1968-05-24       Impact factor: 47.728

9.  Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency.

Authors:  J J Pisano; J S Finlayson; M P Peyton; Y Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.

Authors:  L Lorand; T Urayama; J W De Kiewiet; H L Nossel
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  1 in total

1.  Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.

Authors:  F Rodeghiero; G C Castaman; E Di Bona; M Ruggeri; E Dini
Journal:  Blut       Date:  1987-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.